GLP-1 pills are coming, and they could revolutionize weight-loss
Sep 17, 2024 · Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience. But she and other doctors also warn about the potential for misuse, a...
New GLP-1 drugs promise weight loss and health benefits - NBC News
June 23, 2024, 5:46 PM UTC. By Berkeley Lovelace Jr. The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo...
Many people using GLP-1s for weight loss stop treatment ... - CNN
May 21, 2024 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
FDA clarifies policies for compounders as national GLP-1 supply …
The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved.
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
Aug 12, 2024 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
The Crackdown on Compounded GLP-1 Meds Has Begun
Oct 10, 2024 · Eli Lilly has sent cease-and-desist letters to hundreds of compounding pharmacies, telehealth companies, and medical spas making and selling “compounded” versions of tirzepatide.
GLP-1s like Ozempic are among the most important drug …
Oct 24, 2024 · A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists.
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
Oct 30, 2023 · Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
HRS9531 is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, offering a treatment option for individuals with overweight or obesity, as well as type 2 diabetes. This Phase 2 study evaluated the efficacy and safety of …
After GLP-1, what’s next for weight loss? - Nature
Jun 6, 2023 · The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the...